Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.
Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.
复制标题
DOI:
10.1039/c2ib20125a
复制
发表时间:
2013-01
期刊:
影响因子:
--
通讯作者:
Dhar S
中科院分区:
文献类型:
--
作者:
Marrache S;Choi JH;Tundup S;Zaver D;Harn DA;Dhar S
A therapeutic technology that combines the phototoxic and immune-stimulating ability of photodynamic therapy (PDT) with the widespread effectiveness of the immune system can be very promising to treat metastatic breast cancer. We speculated that the knowledge of molecular mechanisms of existing multi-component therapies could provide clues to aid the discovery of new combinations of an immunostimulant with a photosensitizer (PS) using a nanoparticle (NP) delivery platform. Therapeutic challenges when administering therapeutic combinations include the choice of dosages to reduce side effects, the definitive delivery of the correct drug ratio, and exposure to the targets of interest. These factors are very difficult to achieve when drugs are individually administered. By combining controlled release polymer-based NP drug delivery approaches, we were able to differentially deliver zinc phthalocyanine (ZnPc) based PS to metastatic breast cancer cells along with CpG-ODN, a single-stranded DNA that is a known immunostimulant to manage the distant tumors in a temporally regulated manner resulting in more effective management of deadly metastatic breast cancer. We encapsulated ZnPc which is a long-wavelength absorbing PS within a polymeric NP core made up of poly(D,L-lactic-co-glycolic acid)-b-poly(ethylene glycol) (PLGA-b-PEG). After coating the outside of the polymeric core with gold NPs (AuNPs), we further modified the AuNP surface with CpG-ODN. In vitro cytotoxicity using 4T1 metastatic mouse breast carcinoma cells shows significant photocytotoxicity of the hybrid NPs containing both ZnPc and CpG-ODN after irradiation with a 660 nm LASER light and this activity was remarkably better than either treatment alone. Treatment of mouse bone marrow derived dendritic cells with the PDT-killed 4T1 cell lysate shows that the combination of PDT with a synergistic immunostimulant in a single NP system results in significant immune response, which can be used for the treatment of metastatic cancer.
登录
查看更多内容
影响因子:
4.9
作者:
Alexis F;Pridgen E;Molnar LK;Farokhzad OC
通讯作者:
Farokhzad OC
DOI:
10.1089/oli.1.1996.6.133
发表时间:
1996-06-01
期刊:
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
影响因子:
--
作者:
Krieg, AM;Matson, S;Fisher, E
通讯作者:
Fisher, E
DOI:
10.1073/pnas.96.16.9305
发表时间:
1999-08-03
影响因子:
11.1
作者:
Hartmann, G;Weiner, GJ;Krieg, AM
通讯作者:
Krieg, AM
影响因子:
4.4
作者:
Gollnick SO;Brackett CM
通讯作者:
Brackett CM
DOI:
10.1039/c0pp00326c
发表时间:
2011-05
期刊:
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
影响因子:
--
作者:
St Denis TG;Aziz K;Waheed AA;Huang YY;Sharma SK;Mroz P;Hamblin MR
通讯作者:
Hamblin MR